U.S. Markets close in 5 hrs 56 mins

Alexion’s Soliris Continues to See Growth

Kenneth Smith
Alexion’s Soliris Continues to See Growth

Alexion Pharmaceuticals’ (ALXN) products on the market include Soliris, Strensiq, and Kanuma. Alexion’s Soliris, a humanized monoclonal antibody, is targeted for treating inflammation associated with chronic disorders in hematology, nephrology, and neurology.